文献速递角膜与眼表疾病

局部黏痰溶解剂对泪液及眼表的影响:一种可行的黏蛋白缺乏型干眼动物模型

Effects of Topical Mucolytic Agents on the Tears and Ocular Surface: A Plausible Animal Model of Mucin-Deficient Dry Eye.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2018-01-01

本研究在大鼠中局部给予10% N-乙酰半胱氨酸(NAC)每日4次共5天,评估泪液和眼表变化。结果显示NAC组泪液分泌、角膜湿润能力、泪液MUC5AC浓度及结膜杯状细胞数量显著下降,角膜荧光素和玫瑰红评分显著升高,并出现上皮细胞层和微绒毛损伤;3%地夸磷索治疗5天效果甚微。结论认为局部10% NAC通过促使MUC16破坏和释放诱导眼表损伤和泪膜不稳定,该模型可用于黏蛋白缺乏型干眼研究。

要点

  • 局部10% NAC每日4次共5天可显著降低大鼠泪液分泌、角膜湿润能力和结膜杯状细胞数量。
  • NAC组泪液MUC5AC浓度显著下降,角膜荧光素和玫瑰红评分显著升高。
  • 该模型通过MUC16破坏和释放导致泪膜不稳定,可用于黏蛋白缺乏型干眼研究。

核心结论

  • 局部给予10% NAC可通过促使MUC16破坏和释放诱导眼表损伤和泪膜不稳定,该动物模型可用于研究干眼病尤其是黏蛋白缺乏亚型。

研究设计与样本

  • 在雄性Sprague-Dawley大鼠中局部给予10% NAC每日4次共5天建立NAC处理模型,评估临床参数及黏蛋白蛋白和基因表达,并观察结膜上皮和杯状细胞改变。

主要发现

  • 与对照组相比,NAC组泪液分泌、角膜湿润能力、泪液MUC5AC浓度和结膜杯状细胞数量均显著下降(均P < 0.01)。
  • 与对照组相比,NAC组角膜荧光素评分和玫瑰红评分显著升高(分别为P < 0.05和P < 0.01)。
  • H&E染色和扫描电镜清晰显示NAC组上皮细胞层和微绒毛损伤。
  • MUC16基因表达无显著差异,但NAC组泪膜和眼表组织MUC16浓度较对照组显著升高(分别为P < 0.01和P < 0.05)。
  • 3%地夸磷索治疗5天对NAC处理大鼠眼治疗效果甚微。

临床怎么用

  • 该模型可用于干眼病尤其是黏蛋白缺乏亚型的基础研究,局部10% NAC每日4次共5天可复制眼表损伤和泪膜不稳定表型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: A topical mucolytic agent, N-acetylcysteine (NAC), has been used to create an animal model without the intestinal mucus layer. In this study, we investigated the effects of topical NAC on the tears and ocular surface. METHODS: NAC-treated models were established by topically administering 10% NAC four times daily for 5 days in male Sprague-Dawley rats. Clinical parameters and the expression of mucin proteins and genes were evaluated. Alterations in the conjunctival epithelium and goblet cells were observed. RESULTS: The NAC group showed significant decreases in tear secretion, corneal wetting ability, tear MUC5AC concentration, and conjunctival goblet cell numbers as compared with the control group (all P < 0.01). In addition, significant increases in corneal fluorescein score and rose bengal scores were observed in the NAC group versus in the control group (P < 0.05 and P < 0.01, respectively). Hematoxylin and eosin (H&E) staining and scanning electron microscopy clearly showed damage in the epithelial cell layer and microvilli of the NAC group. Although there was no significant difference in MUC16 gene expression, the MUC16 concentration of the tear film and ocular surface tissue was significantly increased in the NAC group versus in the control group (P < 0.01 and P < 0.05, respectively). Five-day treatment with 3% diquafosol had minimal therapeutic effect in NAC-treated rat eyes. CONCLUSIONS: Topical administration of 10% NAC induced ocular surface damage and tear film instability by prompting MUC16 disruption and release from the ocular surface. This animal model could be used to study dry eye disease, especially the mucin-deficiency subtype.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Li X, Kang B, Woo IH, et al. Effects of Topical Mucolytic Agents on the Tears and Ocular Surface: A Plausible Animal Model of Mucin-Deficient Dry Eye. Invest Ophthalmol Vis Sci. 2018. PMID: 30025127. doi:10.1167/iovs.18-23860

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。